
USC Michelson CSI-Cancer
@uscmichelsoncsi
ID: 1038185789232795649
http://kuhn.usc.edu 07-09-2018 22:02:35
386 Tweet
230 Takipçi
142 Takip Edilen

Big day for BLOODPAC's collaborative studies with The Breast Cancer Research Foundation and the Prostate Cancer Foundation! Both organizations shared updates on studies that began in 2016. Thank you to both organizations for their early commitment and support of BLOODPAC's mission!



⭐ Thanks to Jorge Nieva for stopping by for a great interview about his #WCLC24 abstract on real-world outcomes and treatment patterns after first-line osimertinib in patients with advanced NSCLC & uncommon EGFR mutations! ➡️ Stay tuned for the interview: buff.ly/3Tl3kY6


Immunotherapy has been less effective in prostate cancer vs. other cancers. Dr. Saul Priceman of City of Hope discusses these limitations and why our immune system often doesn't recognize prostate cancer cells. How can we make immunotherapy more effective?




We're thrilled to introduce our new Technology Licensing Manager, Nikki Higa! She has expertise in the life sciences, specializing in diagnostics, cancer, and precision medicine. Nikki just defended her #PhD and was a graduate research assistant at USC Michelson CSI-Cancer! 🎉 🔬 🧬


Exciting insights on UTUC: advancements in Liquid biopsy, CTCs, and biomarkers! Great talk by Dr. Hooman Djaladat at #7PracticalUrology USC Urology USC Michelson CSI-Cancer




His goal? Make science feel less intimidating, more human. Meet USC Dornsife College of Letters, Arts & Sciences's Srikar Kolluru: science writer, cancer researcher, shelter volunteer, and future doctor. dornsife.usc.edu/news/stories/g…






A huge thanks to Jorge Nieva, of Keck School of Medicine of USC, who stopped by during #BTGLung2025 to talk about the management of ALK rearrangements in NSCLC! Check out our site for exclusive insights from Dr Nieva and more! #lcsm #oncology onclive.com/bridging-the-g…


